Junko Oshima Selected Research

Macular Degeneration (Age-Related Maculopathy)

3/2008

Health-protective and adverse effects of the apolipoprotein E epsilon2 allele in older men.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junko Oshima Research Topics

Disease

13	Werner Syndrome (Werner's Syndrome) 01/2022 - 01/2003
8	Progeria (Hutchinson Gilford Syndrome) 01/2022 - 12/2005
5	Laminopathies 01/2022 - 08/2003
5	Genomic Instability 01/2018 - 09/2008
4	Premature Aging 05/2020 - 02/2009
2	Neoplasms (Cancer) 01/2020 - 10/2017
2	Alzheimer Disease (Alzheimer's Disease) 02/2016 - 03/2008
2	Carcinogenesis 01/2016 - 09/2008
2	Atherosclerosis 03/2008 - 12/2005
1	Down Syndrome (Down's Syndrome) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Deafness (Deaf Mutism) 01/2020
1	Lipodystrophy 01/2020
1	Hypersensitivity (Allergy) 01/2020
1	Bloom Syndrome 01/2016
1	Aicardi-Goutieres syndrome 10/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2011
1	Mucopolysaccharidosis II (Hunter Syndrome) 07/2011
1	Memory Disorders (Memory Loss) 04/2010
1	Muscular Dystrophies (Muscular Dystrophy) 09/2009
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2009
1	Emphysema 02/2009
1	Frailty 05/2008
1	Colorectal Neoplasms (Colorectal Cancer) 03/2008
1	Macular Degeneration (Age-Related Maculopathy) 03/2008
1	Coronary Disease (Coronary Heart Disease) 03/2008
1	Insulin Resistance 12/2005
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 12/2005
1	Glucose Intolerance 12/2005
1	Hypertriglyceridemia 12/2005
1	Dementia (Dementias) 09/2002

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
7	RecQ HelicasesIBA 01/2022 - 07/2003
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2008
6	Lamin Type A (Lamin A)IBA 10/2020 - 08/2003
2	Exonucleases (3' 5' Exonuclease)IBA 01/2020 - 09/2005
2	Protein Isoforms (Isoforms)IBA 08/2015 - 04/2010
2	Apolipoproteins E (ApoE)IBA 05/2008 - 03/2008
1	remdesivirIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	CytokinesIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	Virus ReceptorsIBA 01/2022
1	ruxolitinibIBA 01/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	beta CateninIBA 01/2022
1	Gemcitabine FDA Link 01/2020
1	Transcription Factors (Transcription Factor)IBA 10/2019
1	RNA Polymerase II (RNA Polymerase B)IBA 10/2019
1	Biomarkers (Surrogate Marker)IBA 07/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2017
1	Peptides (Polypeptides)IBA 02/2016
1	Amyloid beta-PeptidesIBA 02/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	LaminsIBA 08/2015
1	prelamin AIBA 08/2015
1	EnzymesIBA 07/2011
1	DystrophinIBA 09/2009
1	SmokeIBA 02/2009
1	ApolipoproteinsIBA 03/2008
1	TransferasesIBA 06/2007
1	ProcollagenIBA 01/2007
1	CollagenIBA 01/2007
1	NucleotidesIBA 12/2005
1	Insulin (Novolin)FDA Link 12/2005
1	Presenilin-1IBA 09/2002

Therapy/Procedure

1	Precision Medicine 01/2018
1	Activities of Daily Living (ADL) 03/2008
1	Therapeutics 06/2007